A Clinical Trial to Evaluate the Safety, Efficacy and Immune Responses After Vaccination With an Investigational RNA-based Vaccine Against Malaria
Clinical trial NCT06069544 · COMPLETED
Trial details
- NCT number
- NCT06069544
- Sponsor
- BioNTech SE
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-13
- Primary completion
- 2025-05-28
- Enrollment
- 163
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.